181 related articles for article (PubMed ID: 21197960)
1. Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers.
Callahan J; Kopečkov P; Kopeček J
Biomacromolecules; 2009 Jul; 10(7):1704-14. PubMed ID: 21197960
[TBL] [Abstract][Full Text] [Related]
2. Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics.
Liu J; Bauer H; Callahan J; Kopecková P; Pan H; Kopecek J
J Control Release; 2010 Apr; 143(1):71-9. PubMed ID: 20043962
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.
Mitra A; Nan A; Ghandehari H; McNeill E; Mulholland J; Line BR
Pharm Res; 2004 Jul; 21(7):1153-9. PubMed ID: 15290854
[TBL] [Abstract][Full Text] [Related]
4. The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.
Jensen KD; Kopecková P; Bridge JH; Kopecek J
AAPS PharmSci; 2001; 3(4):E32. PubMed ID: 12049495
[TBL] [Abstract][Full Text] [Related]
5. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
Ding H; Kopecková P; Kopecek J
J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
7. Endocytotic uptake of HPMA-based polymers by different cancer cells: impact of extracellular acidosis and hypoxia.
Gündel D; Allmeroth M; Reime S; Zentel R; Thews O
Int J Nanomedicine; 2017; 12():5571-5584. PubMed ID: 28831253
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.
Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026
[TBL] [Abstract][Full Text] [Related]
9. Interaction of N-(2-hydroxypropyl)methacrylamide based homo, random and block copolymers with primary immune cells.
Weilbächer M; Allmeroth M; Hemmelmann M; Ritz S; Mailänder V; Bopp T; Barz M; Zentel R; Becker C
J Biomed Nanotechnol; 2014 Jan; 10(1):81-91. PubMed ID: 24724500
[TBL] [Abstract][Full Text] [Related]
10. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers.
Oupický D; Konák C; Ulbrich K; Wolfert MA; Seymour LW
J Control Release; 2000 Mar; 65(1-2):149-71. PubMed ID: 10699278
[TBL] [Abstract][Full Text] [Related]
11. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
[TBL] [Abstract][Full Text] [Related]
12. Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery.
Shi J; Johnson RN; Schellinger JG; Carlson PM; Pun SH
Int J Pharm; 2012 May; 427(1):113-22. PubMed ID: 21893178
[TBL] [Abstract][Full Text] [Related]
13. Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.
Callahan J; Kopecek J
Biomacromolecules; 2006 Aug; 7(8):2347-56. PubMed ID: 16903681
[TBL] [Abstract][Full Text] [Related]
14. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Golan M; Feinshtein V; David A
Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
[TBL] [Abstract][Full Text] [Related]
15. Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.
Yang Y; Li L; Zhou Z; Yang Q; Liu C; Huang Y
Mol Pharm; 2014 Oct; 11(10):3251-60. PubMed ID: 24955652
[TBL] [Abstract][Full Text] [Related]
16. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.
Seymour LW; Duncan R; Strohalm J; Kopecek J
J Biomed Mater Res; 1987 Nov; 21(11):1341-58. PubMed ID: 3680316
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
Buckway B; Wang Y; Ray A; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
[TBL] [Abstract][Full Text] [Related]
18. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
[TBL] [Abstract][Full Text] [Related]
19. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency.
Barz M; Armiñán A; Canal F; Wolf F; Koynov K; Frey H; Zentel R; Vicent MJ
J Control Release; 2012 Oct; 163(1):63-74. PubMed ID: 22613881
[TBL] [Abstract][Full Text] [Related]
20. Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.
Sadekar S; Ray A; Janàt-Amsbury M; Peterson CM; Ghandehari H
Biomacromolecules; 2011 Jan; 12(1):88-96. PubMed ID: 21128624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
